Cargando…

Effects of intravenous oxycodone alone or in combination with naltrexone on measures of respiratory depression: a randomized placebo-controlled study

BACKGROUND: Abuse of prescription opioids, particularly by intravenous (IV) administration, can cause respiratory depression and death. ALO-02, an abuse-deterrent opioid formulation, is designed to release sequestered naltrexone upon manipulation by crushing, thereby antagonizing the pharmacologic e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bass, Almasa, Webster, Lynn R., Matschke, Kyle T., Malhotra, Bimal K., Wolfram, Gernot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360639/ https://www.ncbi.nlm.nih.gov/pubmed/30746121 http://dx.doi.org/10.1177/2042098618821274

Ejemplares similares

Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid Users
por: Setnik, Beatrice, et al.
Publicado: (2017)

Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain
por: Weil, Arnold J., et al.
Publicado: (2017)

Randomized, double-blind, placebo-controlled and active-controlled study to assess the relative abuse potential of oxycodone HCl-niacin tablets compared with oxycodone alone in nondependent, recreational opioid users
por: Webster, Lynn R, et al.
Publicado: (2012)

A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration on Respiratory Drive
por: Webster, Lynn R., et al.
Publicado: (2020)

Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide
por: Goli, Veeraindar, et al.
Publicado: (2012)

Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users
por: Webster, Lynn R., et al.
Publicado: (2012)

Effects of sedative psychotropic drugs combined with oxycodone on respiratory depression in the rat
por: Xu, Lin, et al.
Publicado: (2021)

Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized Study
por: Webster, Lynn R., et al.
Publicado: (2019)

Effects of sex and estrous cycle on intravenous oxycodone self-administration and the reinstatement of oxycodone-seeking behavior in rats
por: Hinds, Nicole M., et al.
Publicado: (2023)

Effects of sex and estrous cycle on intravenous oxycodone self-administration and the reinstatement of oxycodone-seeking behavior in rats
por: Hinds, Nicole M., et al.
Publicado: (2023)

Relapsing thrombotic microangiopathy and intravenous sustained-release oxycodone
por: Nataatmadja, Melissa, et al.
Publicado: (2016)

Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product
por: Pergolizzi, Joseph V, et al.
Publicado: (2018)

Voluntary alcohol intake alters the motivation to seek intravenous oxycodone and neuronal activation during the reinstatement of oxycodone and sucrose seeking
por: Wilkinson, Courtney S., et al.
Publicado: (2023)

Voluntary alcohol intake alters the motivation to seek intravenous oxycodone and neuronal activation during the reinstatement of oxycodone and sucrose seeking
por: Wilkinson, Courtney S., et al.
Publicado: (2023)

Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients
por: Villesen, Hanne H, et al.
Publicado: (2007)

Randomized Crossover Trial to Compare Abuse Liability of Intravenous Remimazolam Versus Intravenous Midazolam and Placebo in Recreational Central Nervous System Depressant Users
por: Schippers, Frank, et al.
Publicado: (2020)

Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed‐Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin
por: Sahasrabudhe, Vaishali, et al.
Publicado: (2018)

Pharmacokinetics of Buprenorphine Buccal Film and Orally-administered Oxycodone in a Respiratory Study: An Analysis of Secondary Outcomes from a Randomized Controlled Trial
por: Webster, Lynn R., et al.
Publicado: (2022)

Effect of intravenous oxycodone on the physiologic responses to extubation following general anesthesia
por: Jiang, Menglu, et al.
Publicado: (2021)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Bioequivalence of Ertugliflozin/Sitagliptin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components
por: Fediuk, Daryl J., et al.
Publicado: (2019)

Abuse Potential of Intravenous Oxycodone/Naloxone Solution in Nondependent Recreational Drug Users
por: Colucci, Salvatore V., et al.
Publicado: (2014)

Effects of an Oxycodone Conjugate Vaccine on Oxycodone Self-Administration and Oxycodone-Induced Brain Gene Expression in Rats
por: Pravetoni, Marco, et al.
Publicado: (2014)

Naltrexone as a Treatment for Heroin Dependence and its relationship with Depression
por: Kak, Insha Mehraj, et al.
Publicado: (2022)

Naltrexone during pain conditioning: A double-blind placebo-controlled experimental trial
por: Pontén, Moa, et al.
Publicado: (2020)

A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Human Abuse Potential Study of Oxycodone ARIR, a Novel, Immediate-Release, Abuse-Deterrent Formulation
por: Webster, Lynn R, et al.
Publicado: (2019)

Respiratory effects of oral mitragynine and oxycodone in a rodent model
por: Henningfield, Jack E., et al.
Publicado: (2022)

A comparison of oxycodone and fentanyl in intravenous patient-controlled analgesia after laparoscopic hysterectomy
por: Kim, Nan-Seol, et al.
Publicado: (2015)

Effect of preemptive intravenous oxycodone on low-dose bupivacaine spinal anesthesia with intrathecal sufentanil
por: Wang, Jinguo, et al.
Publicado: (2015)

Effect of preemptive analgesia with intravenous oxycodone in the patients undergoing laparoscopic resection of ovarian tumor
por: Wang, Na, et al.
Publicado: (2015)

O-Benzoylnaltrexone
por: Yang, Rui, et al.
Publicado: (2013)

Asymmetric synthesis of (–)-naltrexone
por: Dongbang, Sun, et al.
Publicado: (2018)

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
por: Colquhoun, Ross M.
Publicado: (2013)

Generalized familial benign chronic pemphigus (Hailey-Hailey disease) treated successfully with low-dose naltrexone
por: Kollman, Natalie, et al.
Publicado: (2018)

Combination of Naltrexone and Isotretinoin for the Treatment of Darier Disease
por: Costa, Tomás, et al.
Publicado: (2023)

Intravenous Oxycodone versus Intravenous Morphine in Cancer Pain: A Randomized, Open-Label, Parallel-Group, Active-Control Study
por: Lee, Kyung-Hee, et al.
Publicado: (2017)

Oral versus patient-controlled intravenous administration of oxycodone for pain relief after cesarean section
por: Mäkelä, Katja, et al.
Publicado: (2019)

Effective dose of intravenous oxycodone depending on sex and age for attenuation of intubation-related hemodynamic responses
por: SO, Keum Young, et al.
Publicado: (2021)

Oxycodone-induced dopaminergic and respiratory effects are modulated by deep brain stimulation
por: Yuen, Jason, et al.
Publicado: (2023)

Naltrexone‐induced drug eruption
por: Heck, Johannes, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sbb2ej00jbrane215p9hth26do